X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (112) 112
life sciences & biomedicine (109) 109
humans (95) 95
oncology (88) 88
male (43) 43
female (42) 42
lung neoplasms - drug therapy (40) 40
lung neoplasms - genetics (38) 38
carcinoma, non-small-cell lung - drug therapy (37) 37
middle aged (37) 37
carcinoma, non-small-cell lung - genetics (36) 36
chemistry (30) 30
metallurgy (30) 30
aged (29) 29
lung cancer (27) 27
lung neoplasms - pathology (27) 27
adult (26) 26
biochemistry (26) 26
carcinoma, non-small-cell lung - pathology (26) 26
beer (25) 25
compositions or test papers therefor (25) 25
condition-responsive control in microbiological orenzymological processes (25) 25
enzymology (25) 25
measuring or testing processes involving enzymes, nucleicacids or microorganisms (25) 25
microbiology (25) 25
mutation or genetic engineering (25) 25
processes of preparing such compositions (25) 25
spirits (25) 25
vinegar (25) 25
wine (25) 25
mutation (24) 24
investigating or analysing materials by determining theirchemical or physical properties (23) 23
measuring (23) 23
physics (23) 23
testing (23) 23
human necessities (21) 21
hygiene (21) 21
medical or veterinary science (21) 21
preparations for medical, dental, or toilet purposes (21) 21
protein kinase inhibitors - therapeutic use (21) 21
respiratory system (21) 21
care and treatment (19) 19
lung cancer, non-small cell (19) 19
cancer (18) 18
animals (16) 16
crizotinib (16) 16
gene rearrangement (16) 16
nsclc (16) 16
non-small cell lung cancer (15) 15
oncogene proteins, fusion - genetics (15) 15
proto-oncogene proteins - genetics (15) 15
specific therapeutic activity of chemical compounds ormedicinal preparations (15) 15
abridged index medicus (14) 14
aged, 80 and over (14) 14
alk (14) 14
cell line, tumor (14) 14
lung neoplasms - enzymology (14) 14
treatment outcome (14) 14
carcinoma, non-small-cell lung - enzymology (13) 13
egfr (13) 13
molecular targeted therapy (13) 13
protein kinase inhibitors - pharmacology (13) 13
receptor protein-tyrosine kinases - genetics (13) 13
research (13) 13
antineoplastic agents - therapeutic use (12) 12
cell biology (12) 12
kinases (12) 12
protein-tyrosine kinases - genetics (12) 12
retrospective studies (12) 12
ros1 (12) 12
genetic aspects (11) 11
lung neoplasms - metabolism (11) 11
metastasis (11) 11
neoplasm staging (11) 11
patients (11) 11
pulmonary and respiratory medicine (11) 11
pyrazoles - therapeutic use (11) 11
receptor protein-tyrosine kinases - antagonists & inhibitors (11) 11
tumors (11) 11
analysis (10) 10
anaplastic lymphoma kinase (10) 10
drug resistance (10) 10
non-small cell lung carcinoma (10) 10
oncogenes (10) 10
young adult (10) 10
cancer therapies (9) 9
carcinoma, non-small-cell lung - mortality (9) 9
disease-free survival (9) 9
epidermal growth factor receptors (9) 9
health aspects (9) 9
hematology, oncology and palliative medicine (9) 9
hemic and lymphatic diseases (9) 9
pyridines - therapeutic use (9) 9
receptor, epidermal growth factor - genetics (9) 9
antineoplastic combined chemotherapy protocols - therapeutic use (8) 8
carcinoma, non-small-cell lung - metabolism (8) 8
drug resistance, neoplasm - genetics (8) 8
in situ hybridization, fluorescence (8) 8
lung neoplasms - mortality (8) 8
receptor, epidermal growth factor - antagonists & inhibitors (8) 8
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (219) 219
French (15) 15
German (7) 7
Spanish (3) 3
Chinese (2) 2
Korean (2) 2
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 02/2018, Volume 378, Issue 8, pp. 731 - 739
Journal Article
The New England journal of medicine, ISSN 1533-4406, 11/2014, Volume 371, Issue 21, pp. 1963 - 1971
Journal Article
The lancet oncology, ISSN 1470-2045, 10/2011, Volume 12, Issue 11, pp. 1004 - 1012
Journal Article
The New England journal of medicine, ISSN 1533-4406, 04/2015, Volume 372, Issue 18, pp. 1700 - 1709
Patients with non–small-cell lung cancer and mutated epidermal growth factor receptors who develop resistance to EGFR inhibitors through a particular mutation... 
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Lung Neoplasms - drug therapy | Humans | Middle Aged | ErbB Receptors - genetics | Lung Neoplasms - pathology | Male | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Acrylamides - pharmacokinetics | Dose-Response Relationship, Drug | Hyperglycemia - chemically induced | Antineoplastic Agents - adverse effects | Female | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Protein Kinase Inhibitors - pharmacokinetics | ErbB Receptors - antagonists & inhibitors | Carcinoma, Non-Small-Cell Lung - genetics | Pyrimidines - administration & dosage | Protein Kinase Inhibitors - administration & dosage | Drug Resistance, Neoplasm - genetics | Acrylamides - administration & dosage | Pyrimidines - adverse effects | Pyrimidines - pharmacokinetics | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Mutation | Acrylamides - adverse effects | Clinical trials | Care and treatment | Usage | Diagnosis | Lung cancer, Non-small cell | Hyperglycemia | Chemotherapy | Epidermal growth factor | Inhibitor drugs | Epidermal growth factor receptors | Lung cancer | Genes | Non-small cell lung carcinoma | Antitumor activity | Pharmacokinetics | Patients | Index Medicus | Abridged Index Medicus
Journal Article
Nature reviews. Clinical oncology, ISSN 1759-4774, 05/2012, Volume 9, Issue 5, pp. 268 - 277
Journal Article
Journal Article
PloS one, ISSN 1932-6203, 11/2010, Volume 5, Issue 11, pp. e14117 - e14117
...Author(s): Kathryn E. Ware 1,*, Marianne E. Marshall 1, Lydia R. Heasley 1, Lindsay Marek 1, Trista K. Hinz 1, Paula Hercule 1, Barbara A. Helfrich 2, Robert C... 
Fibroblast Growth Factor 7 - pharmacology | Receptor, Fibroblast Growth Factor, Type 2 - metabolism | Coculture Techniques | Humans | Lung Neoplasms - metabolism | Fibroblast Growth Factor 2 - pharmacology | Lung Neoplasms - pathology | Extracellular Signal-Regulated MAP Kinases - metabolism | Receptor, Fibroblast Growth Factor, Type 3 - metabolism | Gene Expression Regulation, Neoplastic - drug effects | Fibroblasts - metabolism | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Receptor, Fibroblast Growth Factor, Type 3 - genetics | Carcinoma, Non-Small-Cell Lung - genetics | Carcinoma, Non-Small-Cell Lung - metabolism | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Drug Resistance, Neoplasm - genetics | Signal Transduction - drug effects | Fibroblasts - drug effects | Cell Line, Tumor | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Fibroblasts - cytology | Protein Kinase Inhibitors - pharmacology | Quinazolines - pharmacology | Receptor, Fibroblast Growth Factor, Type 2 - genetics | Tyrosine | Phenols | Fibroblast growth factors | RNA | Analysis | Luciferase | Fibroblast growth factor | Biotechnology | Transcription | Gene regulation | Lung cancer | Biology | Kinases | Cell adhesion & migration | Morphogenesis | Epidermal growth factor | Fibroblast growth factor receptor 7 | Gefitinib | Protein-tyrosine kinase | Fibroblast growth factor receptor 2 | Fibroblast growth factor 2 | Epidermal growth factor receptors | Extracellular signal-regulated kinase | Non-small cell lung carcinoma | Gene expression | Src protein | Self sufficiency | Pulmonary hypertension | Studies | Signaling | Inhibitors | Monoclonal antibodies | Ligands | Mutation | Tumors | Fibroblast growth factor receptors | Index Medicus
Journal Article
PloS one, ISSN 1932-6203, 12/2013, Volume 8, Issue 12, pp. e82236 - e82236
.... Heasley 3, Aik-Choon Tan 1, D. Ross Camidge 1, Marileila Varella-Garcia 1, Robert C. Doebele 1,* Introduction Lung cancer, of which approximately 80-85... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Protein-Tyrosine Kinases - metabolism | Humans | Lung Neoplasms - metabolism | Lung Neoplasms - pathology | Protein-Tyrosine Kinases - genetics | Receptor, Epidermal Growth Factor - metabolism | Pyrazoles - pharmacology | Pyridines - therapeutic use | Carcinoma, Non-Small-Cell Lung - pathology | Proto-Oncogene Proteins - metabolism | Cell Survival - drug effects | Proto-Oncogene Proteins - antagonists & inhibitors | Carcinoma, Non-Small-Cell Lung - metabolism | Proto-Oncogene Proteins - genetics | Gene Amplification - drug effects | Signal Transduction - drug effects | Cell Line, Tumor | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Cell Proliferation - drug effects | Pyridines - pharmacology | Carcinoma, Non-Small-Cell Lung - drug therapy | Epidermal Growth Factor - pharmacology | Drug Resistance, Neoplasm - drug effects | Protein-Tyrosine Kinases - antagonists & inhibitors | Proteins | Care and treatment | Analysis | Lung cancer, Small cell | Lung cancer, Non-small cell | Health aspects | Phosphotransferases | Patients | Tyrosine | Therapy | Cell survival | Epidermal growth factor receptors | Mesenchyme | Copy number | Lung cancer | Non-small cell lung carcinoma | Histology | Kinases | Signaling | Cell activation | Epidermal growth factor | Inhibitors | Mutation | Inhibition | Target acquisition |